Canada - English - Health Canada

jedmon products ltd. - magnesium sulfate - powder for solution - 100% - magnesium sulfate 100% - cathartics and laxatives

Canada - English - Health Canada

jedmon products ltd. - benzalkonium chloride; alkyl dimethyl ethylbenzyl ammonium chloride - lotion - 0.05%; 0.05% - benzalkonium chloride 0.05%; alkyl dimethyl ethylbenzyl ammonium chloride 0.05% - miscellaneous local anti-infectives

Canada - English - Health Canada

jedmon products ltd. - benzalkonium chloride; octyl decyl dimethyl ammonium chloride; dioctyl dimethyl ammonium chloride; didecyl dimethyl ammonium chloride - liquid - 6.6%; 4.9%; 2.0%; 2.5% - benzalkonium chloride 6.6%; octyl decyl dimethyl ammonium chloride 4.9%; dioctyl dimethyl ammonium chloride 2.0%; didecyl dimethyl ammonium chloride 2.5% - disinfectants (for agents used on object)

United States - English - NLM (National Library of Medicine)

merck sharp & dohme corp. - measles virus strain enders' attenuated edmonston live antigen (unii: mfz8i7277d) (measles virus strain enders' attenuated edmonston live antigen - unii:mfz8i7277d) - measles virus strain enders' attenuated edmonston live antigen 1000 [tcid_50] in 0.5 ml

United States - English - NLM (National Library of Medicine)

merck sharp & dohme llc - measles virus strain enders' attenuated edmonston live antigen (unii: mfz8i7277d) (measles virus strain enders' attenuated edmonston live antigen - unii:mfz8i7277d), mumps virus strain b level jeryl lynn live antigen (unii: 47qb6mx9ku) (mumps virus strain b level jeryl lynn live antigen - unii:47qb6mx9ku), rubella virus strain wistar ra 27/3 live antigen (unii: 52202h034z) (rubella virus strain wistar ra 27/3 live antigen - unii:52202h034z), varicella-zoster virus strain oka/merck live antigen (unii: gpv - measles virus strain enders' attenuated edmonston live antigen 1000 [tcid_50] in 0.5 ml - proquad is a vaccine indicated for active immunization for the prevention of measles, mumps, rubella, and varicella in children 12 months through 12 years of age. do not administer proquad to individuals with a history of hypersensitivity to any component of the vaccine (including gelatin) {1} or to a previous dose of m-m-r ii (measles, mumps, rubella, live), proquad or varivax (varicella virus vaccine live) vaccine, or any other measles, mumps, and rubella or varicella-containing vaccine. do not administer proquad to individuals with a history of anaphylaxis to neomycin [see description (11)] . do not administer proquad vaccine to individuals who are immunodeficient or immunosuppressed due to disease or medical therapy. measles inclusion body encephalitis {2} (mibe), pneumonitis {3} and death as a direct consequence of disseminated measles vaccine virus infection have been reported in immunocompromised individuals inadvertently vaccinated with measles-containing vaccine. in this population, disseminated mump

United States - English - NLM (National Library of Medicine)

merck sharp & dohme llc - measles virus strain enders' attenuated edmonston live antigen (unii: mfz8i7277d) (measles virus strain enders' attenuated edmonston live antigen - unii:mfz8i7277d), mumps virus strain b level jeryl lynn live antigen (unii: 47qb6mx9ku) (mumps virus strain b level jeryl lynn live antigen - unii:47qb6mx9ku), rubella virus strain wistar ra 27/3 live antigen (unii: 52202h034z) (rubella virus strain wistar ra 27/3 live antigen - unii:52202h034z) - measles virus strain enders' attenuated edmonston live antigen 1000 [tcid_50] in 0.5 ml - m-m-r ii is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older. do not administer m-m-r ii vaccine to individuals with a history of hypersensitivity to any component of the vaccine (including gelatin) {3} or who have experienced a hypersensitivity reaction following administration of a previous dose of m-m-r ii vaccine or any other measles, mumps and rubella-containing vaccine. do not administer m-m-r ii vaccine to individuals with a history of anaphylaxis to neomycin [see description (11)]. do not administer m-m-r ii vaccine to individuals who are immunodeficient or immunosuppressed due to disease or medical therapy. measles inclusion body encephalitis {4} (mibe), pneumonitis {5} and death as a direct consequence of disseminated measles vaccine virus infection have been reported in immunocompromised individuals inadvertently vaccinated with measles-containing vaccine. in this population, disseminated mumps and rubella vaccin

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - measles virus live attenuated derived from the edmonston b strain mumps virus - jerylynn strain rubella virus (wistar ra 27/3 strain) live attenuated - pdr+solv for soln for inj

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - measles virus - enders edmonston strain mumps virus - jerylynn strain rubella virus - wistar ra27/3 strain - 0.5ml millilitre

Australia - English - Department of Health (Therapeutic Goods Administration)

clifford hallam healthcare pty ltd - 35492 - gown, isolation, single use - a garment made of natural and/or synthetic materials intended to be worn by healthcare providers or visitors to isolate themselves from patients. the isolation gown helps to protect the patient (e.g., burn patients) from the transfer of infectious agents carried by the healthcare provider or visitor; or it may help to protect the healthcare provider or visitor from a contagious agent which has infected the patient. this is a single-use garment.

Australia - English - Department of Health (Therapeutic Goods Administration)

clifford hallam healthcare pty ltd - 35177 - mask, surgical, single use - a device intended to be placed over the nose and mouth of medical personnel to prevent the transmission of airborne organisms during surgery or patient examination. it is made of a flexible porous fabric material that allows the user to breath normally through the mask and typically includes a metal wire along one border to form fit the nose bridge; it is typically held in place with ties that fasten at the back of the user's head. this is a single-use device.